Geriatric characteristics
. | Total . | Age of <65 y . | Age of ≥65 y . | P value . |
---|---|---|---|---|
Number of patients, n (%) | 156 | 81 (51.9) | 75 (48.1) | |
Polypharmacy (≥5) | .033 | |||
Yes, n (%) | 144 (92.3) | 71 (87.7) | 73 (97.3) | |
No, n (%) | 12 (7.7) | 10 (12.3) | 2 (2.7) | |
Excessive polypharmacy (≥10) | .10 | |||
Yes, n (%) | 100 (64.1) | 47 (58.0) | 53 (70.7) | |
No, n (%) | 56 (35.9) | 34 (42.0) | 22 (29.3) | |
Comorbidities (≥4) | .038 | |||
Yes, n (%) | 95 (60.9) | 43 (53.1) | 52 (69.3) | |
No, n (%) | 61 (39.1) | 38 (46.9) | 23 (30.7) | |
Neuropathy | .21 | |||
Yes, n (%) | 109 (69.9) | 53 (65.4) | 56 (74.7) | |
No, n (%) | 47 (30.1) | 28 (34.6) | 19 (25.3) | |
Falls | .16 | |||
Yes, n (%) | 34 (21.8) | 14 (17.3) | 20 (26.7) | |
No, n (%) | 122 (78.2) | 67 (82.7) | 55 (73.3) | |
Organ dysfunction∗ | .013 | |||
Yes, n (%) | 40 (25.6) | 14 (17.3) | 26 (34.7) | |
No, n (%) | 116 (74.4) | 67 (82.7) | 49 (65.3) |
. | Total . | Age of <65 y . | Age of ≥65 y . | P value . |
---|---|---|---|---|
Number of patients, n (%) | 156 | 81 (51.9) | 75 (48.1) | |
Polypharmacy (≥5) | .033 | |||
Yes, n (%) | 144 (92.3) | 71 (87.7) | 73 (97.3) | |
No, n (%) | 12 (7.7) | 10 (12.3) | 2 (2.7) | |
Excessive polypharmacy (≥10) | .10 | |||
Yes, n (%) | 100 (64.1) | 47 (58.0) | 53 (70.7) | |
No, n (%) | 56 (35.9) | 34 (42.0) | 22 (29.3) | |
Comorbidities (≥4) | .038 | |||
Yes, n (%) | 95 (60.9) | 43 (53.1) | 52 (69.3) | |
No, n (%) | 61 (39.1) | 38 (46.9) | 23 (30.7) | |
Neuropathy | .21 | |||
Yes, n (%) | 109 (69.9) | 53 (65.4) | 56 (74.7) | |
No, n (%) | 47 (30.1) | 28 (34.6) | 19 (25.3) | |
Falls | .16 | |||
Yes, n (%) | 34 (21.8) | 14 (17.3) | 20 (26.7) | |
No, n (%) | 122 (78.2) | 67 (82.7) | 55 (73.3) | |
Organ dysfunction∗ | .013 | |||
Yes, n (%) | 40 (25.6) | 14 (17.3) | 26 (34.7) | |
No, n (%) | 116 (74.4) | 67 (82.7) | 49 (65.3) |
Bold indicates statistically significant difference between age groups, P < .05.
Refer to supplemental Materials for organ dysfunction definition.